AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | | | | | N/A |
| | Tissue enhanced | 0 |
ADORA2B | Adenosine A2b receptor | | | | | |
| | Tissue enhanced | 0 |
ADTRP | Androgen-dependent TFPI-regulating protein | | | | | N/A |
| | Tissue enhanced | 0 |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | | | | |
|
| | Tissue enhanced | 0 |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | | | | |
|
| | Tissue enhanced | 0 |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | | | | |
|
| | Tissue enhanced | 0 |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | | | | |
|
| | Tissue enhanced | 0 |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | | | | |
|
| | Tissue enhanced | 0 |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | | | | |
|
| | Tissue enhanced | 0 |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | | | | |
|
| | Tissue enhanced | 0 |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | | | | |
|
| | Tissue enhanced | 0 |
C15orf48 | Chromosome 15 open reading frame 48 | | | | |
|
| | Tissue enhanced | 0 |
C2orf72 | Chromosome 2 open reading frame 72 | | | | |
|
| Nucleus Plasma membrane | Tissue enhanced | 0 |
C9orf152 | Chromosome 9 open reading frame 152 | | | | |
|
| Nucleus | Tissue enhanced | 0 |
CA2 | Carbonic anhydrase II | | | | |
|
| | Tissue enhanced | 0 |
CA4 | Carbonic anhydrase IV | | | | |
|
| Vesicles | Tissue enhanced | 0 |
CALML4 | Calmodulin-like 4 | | | | |
|
| Golgi apparatus Nucleus but not nucleoli | Tissue enhanced | 0 |
CCL15 | Chemokine (C-C motif) ligand 15 | | | | | |
| Golgi apparatus Vesicles | Tissue enhanced | 0 |
CD70 | CD70 molecule | | | | | |
| | Tissue enhanced | 0 |
CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 | | | | |
|
| | Tissue enhanced | 0 |
CEA | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000469926} | | | | |
|
| | Tissue enhanced | 0 |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | | | | |
|
| | Tissue enhanced | 0 |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | | | | |
|
| | Tissue enhanced | 0 |
CES3 | Carboxylesterase 3 | | | | |
|
| Nuclear membrane Cytoplasm | Tissue enhanced | 0 |
CKMT1B | Creatine kinase, mitochondrial 1B | | | | |
|
| | Tissue enhanced | 0 |
CLDN23 | Claudin 23 | | | | | |
| | Tissue enhanced | 0 |
CLDN3 | Claudin 3 | | | | |
|
| | Tissue enhanced | 0 |
CPA6 | Carboxypeptidase A6 | | | | | |
| | Tissue enhanced | 0 |
DHRS9 | Dehydrogenase/reductase (SDR family) member 9 | | | | |
|
| | Tissue enhanced | 0 |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | | | | |
|
| Nucleus but not nucleoli Cytoplasm Vesicles | Tissue enhanced | 0 |
EPCAM | Epithelial cell adhesion molecule | | | | |
|
| Nuclear membrane | Tissue enhanced | 0 |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | | | | |
|
| | Tissue enhanced | 0 |
FAM3D | Family with sequence similarity 3, member D | | | | |
|
| | Tissue enhanced | 0 |
FAM83E | Family with sequence similarity 83, member E | | | | |
|
| | Tissue enhanced | 0 |
FAM84A | Family with sequence similarity 84, member A | | | | |
|
| Nucleus | Tissue enhanced | 0 |
FOXD2 | Forkhead box D2 | | | | | |
| | Tissue enhanced | 0 |
FRMD1 | FERM domain containing 1 | | | | |
|
| Cytoskeleton (Actin filaments) | Tissue enhanced | 0 |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | | | | |
|
| | Tissue enhanced | 0 |
FXYD3 | FXYD domain containing ion transport regulator 3 | | | | |
|
| Plasma membrane | Tissue enhanced | 0 |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | | | | |
|
| Nucleoli Cytoplasm Golgi apparatus Vesicles | Tissue enhanced | 0 |
GJD3 | Gap junction protein, delta 3, 31.9kDa | | | | | |
| | Tissue enhanced | 0 |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | | | | | |
| | Tissue enhanced | 0 |
HAVCR1 | Hepatitis A virus cellular receptor 1 | | | | | |
| Vesicles | Tissue enhanced | 0 |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | | | | |
|
| Mitochondria | Tissue enhanced | 0 |
HOXB9 | Homeobox B9 | | | | |
|
| Nucleus but not nucleoli Mitochondria | Tissue enhanced | 0 |
HOXD11 | Homeobox D11 | | | | | |
| Nucleus but not nucleoli | Tissue enhanced | 0 |
HOXD12 | Homeobox D12 | | | | |
|
| | Tissue enhanced | 0 |
ITLN1 | Intelectin 1 (galactofuranose binding) | | | | |
|
| | Tissue enhanced | 0 |
KLK15 | Kallikrein-related peptidase 15 | | | | |
|
| | Tissue enhanced | 0 |
KRT20 | Keratin 20 | | | | |
|
| Cytoskeleton (Intermediate filaments) | Tissue enhanced | 0 |